The 21st International Congress of the European Society of Toxicology In Vitro (ESTIV 2022) will be organised in Barcelona-Sitges, Spain, from 21st to 25th November 2022.
ESTIV congress had to be postponed from 2020 to 2022 due to public health concerns and limitations in international travels. The ESTIV Board also took into consideration the postponement of the World Congress on Alternatives from 2020 to 2021.
The registration to ESTIV 2022 and abstract submission are now open and we invite you to register and submit your valuable scientific work. The Scientific Committee has prepared an attractive scientific programme and we hope that many of you will participate in the congress and submit your abstracts for oral or poster presentation. We are determined to offer an attractive congress with an up-to-date scientific programme and therefore, we have implemented several emerging topics such as the role of in vitro and in silico approaches in COVID-19 research.
The ESTIV congress will start with a pre-congress workshop on bridging across methods in the biosciences (BeAMS): the opportunity of COVID-19 organised jointly with the JRC. The scientific programme offers currently 15 scientific sessions, a lunch session hosted by JSAASE and a post-congress workshop organised by EPISKIN Academy. The ASPIS annual cluster meeting will be a satellite activity open to the public and will present the latest research of the three H2020 consortia (ONTOX, PrecisionTOX and RISKHUNT3R) focusing on NAMs.
If you have already submitted abstracts for ESTIV 2020, you will find them already inserted in the system when you login (using the login details you created for ESTIV 2020). These remain valid for ESTIV 2022 but you will be asked to confirm, edit or reject them. Of course, you will also be able to submit new research for the upcoming congress.Event website Add to my calendar